Skip to main content
. Author manuscript; available in PMC: 2015 Sep 3.
Published in final edited form as: Cell Rep. 2015 Jul 16;12(4):673–683. doi: 10.1016/j.celrep.2015.06.049

Figure 5. Validating the identified genes with different WNV strains, Saint Louis encephalitis virus (SLEV), as well as Neuro-2a and HeLa cells.

Figure 5

The 293FT knockout cells prepared as in Figure 2 were infected with WNV-NY99 (A) or SLEV (B) at MOI=2. The resistance was determined as in Figure 2C. Neuro-2a and HeLa cells were treated as in Figure 2A to generate knockout cells. The knockout efficiency was determined by western blotting, as shown in Figure S4. The knockout cells were infected with the WNV B956 strain (C, Neuro-2a; E, Hela) or the NY99 strain (D, Neuro-2a; F, Hela), and the resistance was determined as in Figure 2C.